SCYNEXIS Integrated Pharmaceutical Solutions drives our client’s success by rapidly solving the toughest drug development problems through integrated analytical and synthetic chemistry in combination with regulatory expertise.
- CMC & QC Solutions
- Impurity Control & Resolution
- Potential Genotoxic Impurities
- Enhanced salt selection for bioavailability
- Chemical Development
- Non-GMP API Synthesis
- cGMP API Synthesis (up to 10 kg)
- Regulatory Support
- CMC Section
SCYNEXIS’ cGMP manufacturing team has conducted a broad range of programs from Phase I material supplies to supporting a NDA submission. The SCYNEXIS integrated analytical team is able to meet the increasing demands, throughout the pharmaceutical development process, for increasingly efficient, sensitive and specific analytical methods for regulatory submissions.
SCYNEXIS has developed a number of unique offerings that provide valued solutions to our customers:
- Non-small Molecule Development
- Impurity Resolution
- Enhanced Salt Selection for Bioavailability
The SCYNEXIS Integrated Pharmaceutical Solutions team would appreciate the opportunity to solve your toughest problems.